Top Deals
Feb. 6, 2014
Capital keeps flowing into biotech sector
Equity markets opened up in a big way for biotech companies last year, clearing the path for dozens of companies to go public and providing ample work for life sciences lawyers.
Daily Journal Staff Writer
Equity markets opened up in a big way for biotech companies last year, clearing the path for dozens of companies to go public and providing ample work for life sciences lawyers.
"There's a huge amount of money flowing into the sector," said Cooley LLP's Barbara Kosacz, a Palo Alto-based life sciences partner whose firm handled numerous biotech IPOs last year. "With all these ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In